首页> 外文学位 >Investigation of fatty acid and cholesterol synthesis using stable isotopes in type 1 diabetes, liver failure, islet and liver transplant, and effect of dietary intervention.
【24h】

Investigation of fatty acid and cholesterol synthesis using stable isotopes in type 1 diabetes, liver failure, islet and liver transplant, and effect of dietary intervention.

机译:使用1型糖尿病,肝衰竭,胰岛和肝移植中的稳定同位素研究脂肪酸和胆固醇的合成,以及饮食干预的效果。

获取原文
获取原文并翻译 | 示例

摘要

Elevated plasma lipids are risk factors for cardiovascular disease (CVD). In certain conditions plasma lipids are normal yet individuals experience increased morbidity. Type 1 diabetes (T1D) is associated with elevated CVD despite normal lipids, while in liver failure low plasma lipids may indicate increasing hepatic damage. Plasma lipids can therefore belie underlying dysregulated lipid metabolism. Islet (ITx) or liver (LTx) transplants represent therapies for T1D and liver failure, respectively, but are associated with altered lipid metabolism attributed to immunosuppressive medications; however, causative mechanisms are unknown. Partial success of dietary therapy in post-transplant patients may be due to interventions limited in scope. Regulation of plasma lipids involve absorption, synthesis, and clearance. These studies examined lipogenesis and cholesterol synthesis using deuterium incorporation.;Plasma cholesterol was lower and triglyceride similar in liver failure patients compared to controls. Lipogenesis was higher while cholesterol synthesis was lower in liver failure compared to controls. Disturbances in lipid synthesis may be influenced by underlying disease, such as hepatitis C.;In ITx and LTx lipogenesis was lower whereas cholesterol synthesis was similar compared to controls. Lipid synthesis is therefore unlikely to contribute to post-transplant hyperlipidemia, inviting investigation of other mechanisms.;Dietary intervention emphasizing fish oil, phytosterols, soy, fibers, and almonds lowered plasma lipids in controls but had mixed effects in transplant subjects. Reduction in plasma lipids occurred in transplant patients with higher baseline lipids, suggesting this intervention may be successful in hyperlipidemic patients; however the potential of this diet intervention requires further study in hyperlipidemic patients. Diet intervention lowered lipogenesis but did not signifiicantly change 24h cholesterol synthesis in controls. Diet did not change 24h lipogenesis or cholesterol synthesis in transplant subjects. Plasma lipid response to dietary therapy was related to baseline cholesterol synthesis and to dietary compliance in transplant subjects. Further study is required to determine if cholesterol synthesis is predictive of response to diet.;In brittle T1D lipogenesis and cholesterol synthesis were similar to healthy controls; however hepatic lipogenesis and cholesterol synthesis tended to be lower in T1D compared to matched control subjects.
机译:血浆脂质升高是心血管疾病(CVD)的危险因素。在某些情况下血浆脂质是正常的,但个体的发病率增加。尽管血脂正常,但1型糖尿病(T1D)与CVD升高有关,而在肝衰竭中,低血脂可能表明肝损害增加。因此,血浆脂质可能是脂质代谢失调的根本原因。 Islet(ITx)或肝(LTx)移植分别代表T1D和肝衰竭的治疗方法,但它们与免疫抑制药物引起的脂质代谢改变有关;但是,致病机制尚不清楚。移植后患者饮食治疗的部分成功可能是由于干预范围有限。血浆脂质的调节涉及吸收,合成和清除。这些研究使用氘掺入法检查脂肪生成和胆固醇合成。与对照组相比,肝衰竭患者血浆胆固醇水平较低,甘油三酯相似。与对照组相比,肝衰竭的脂肪生成较高,而胆固醇合成较低。脂质合成的紊乱可能受到诸如丙型肝炎等潜在疾病的影响;在ITx和LTx中,脂肪生成较低,而胆固醇合成与对照组相似。因此,脂质的合成不太可能导致移植后的高脂血症,从而引发了其他机制的研究。强调鱼油,植物甾醇,大豆,纤维和杏仁的饮食干预降低了对照组的血浆脂质,但对移植对象产生了混合影响。血浆脂质水平降低的患者在基线脂质较高的移植患者中发生,提示这种干预对高脂血症患者可能是成功的。然而,这种饮食干预的潜力需要在高脂血症患者中进行进一步研究。饮食干预降低了脂肪生成,但并未显着改变对照组的24h胆固醇合成。饮食没有改变移植受试者的24小时脂肪生成或胆固醇合成。饮食疗法对血浆脂质的反应与基线胆固醇合成以及移植受试者的饮食依从性有关。需要进一步的研究来确定胆固醇合成是否可预测饮食反应。在脆性T1D脂肪生成和胆固醇合成与健康对照相似;然而,与匹配的对照对象相比,T1D患者的肝脏脂肪生成和胆固醇合成趋于降低。

著录项

  • 作者单位

    University of Alberta (Canada).;

  • 授予单位 University of Alberta (Canada).;
  • 学科 Health Sciences Nutrition.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 364 p.
  • 总页数 364
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 老年病学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号